Cargando…

Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice

Filoviruses of the genus Ebolavirus include 6 species with marked differences in their ability to cause disease in humans. From the highly virulent Ebola virus to the seemingly nonpathogenic Reston virus, case fatality rates can range between 0% and 90%. In order to understand the molecular basis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Escudero-Pérez, Beatriz, Ruibal, Paula, Rottstegge, Monika, Lüdtke, Anja, Port, Julia R., Hartmann, Kristin, Gómez-Medina, Sergio, Müller-Guhl, Jürgen, Nelson, Emily V., Krasemann, Susanne, Rodríguez, Estefanía, Muñoz-Fontela, César
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948759/ https://www.ncbi.nlm.nih.gov/pubmed/31550241 http://dx.doi.org/10.1172/jci.insight.126070

Ejemplares similares

Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination
por: Lüdtke, Anja, et al.
Publicado: (2017)

Risk assessment of Ebola Reston virus in humans in the Philippines
por: Peñas, Johnette A, et al.
Publicado: (2019)

Molecular evidence of Ebola Reston virus infection in Philippine bats
por: Jayme, Sarah I., et al.
Publicado: (2015)

Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors
por: Rottstegge, Monika, et al.
Publicado: (2022)

Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus
por: Bodmer, Bianca S., et al.
Publicado: (2020)

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
por: Koch, Till, et al.
Publicado: (2020)

Sequence of Reston Virus Isolate AZ-1435, an Ebolavirus Isolate Obtained during the 1989–1990 Reston Virus Epizootic in the United States
por: Cornish, Joseph P., et al.
Publicado: (2017)

Insights into Reston virus spillovers and adaption from virus whole genome sequences
por: Albariño, César G., et al.
Publicado: (2017)

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Ebola Virus Disease in Humans: Pathophysiology and Immunity
por: Muñoz-Fontela, César, et al.
Publicado: (2017)

Regulation of Ebola virus VP40 matrix protein by SUMO
por: Baz-Martínez, Maite, et al.
Publicado: (2016)

Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses
por: Brunetti, Jesús Emanuel, et al.
Publicado: (2023)

Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Role of Type I Interferons on Filovirus Pathogenesis
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2019)

Reston Ebolavirus Antibodies in Bats, the Philippines
por: Taniguchi, Satoshi, et al.
Publicado: (2011)

Risks Posed by Reston, the Forgotten Ebolavirus
por: Cantoni, Diego, et al.
Publicado: (2016)

Monocyte‐derived dendritic cells enhance protection against secondary influenza challenge by controlling the switch in CD8(+) T‐cell immunodominance
por: Cruz, Jazmina L. G., et al.
Publicado: (2016)

A seroepidemiologic study of Reston ebolavirus in swine in the Philippines
por: Sayama, Yusuke, et al.
Publicado: (2012)

Restons de bons amis ... gardons nos distances !
Publicado: (2002)

Reemergence of Reston ebolavirus in Cynomolgus Monkeys, the Philippines, 2015
por: Demetria, Catalino, et al.
Publicado: (2018)

Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues
por: Port, Julia R., et al.
Publicado: (2020)

Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease
por: Kerber, Romy, et al.
Publicado: (2018)

Structure of the Reston ebolavirus VP30 C-terminal domain
por: Clifton, Matthew C., et al.
Publicado: (2014)

Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines
por: Taniguchi, Satoshi, et al.
Publicado: (2012)

Quantification of Type I Interferon Inhibition by Viral Proteins: Ebola Virus as a Case Study
por: Locke, Macauley, et al.
Publicado: (2021)

Chloroquine-hydroxychloroquine, restons rigoureux : l’EMA calme le jeu
por: Manus, Jean-Marie
Publicado: (2020)

Development and validation of portable, field-deployable Ebola virus point-of-encounter diagnostic assay for wildlife surveillance
por: Figueroa, Dania M., et al.
Publicado: (2021)

Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus
por: Liu, Xuan, et al.
Publicado: (2017)

Molecular mechanisms of Ebola virus pathogenesis: focus on cell death
por: Falasca, L, et al.
Publicado: (2015)

Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2023)

Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2014)

Unique human immune signature of Ebola virus disease in Guinea
por: Ruibal, Paula, et al.
Publicado: (2016)

646. Activated Macrophages as Pathogenesis Factors in Ebola Virus Disease in Humans
por: McElroy, Anita, et al.
Publicado: (2018)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
por: Zhu, Wenjun, et al.
Publicado: (2019)

Restons de bons amis ... gardons nos distances ! / "Stay friends ... and keep your distance !"
Publicado: (2002)

Analysis of exotic squirrel trade and detection of human infections with variegated squirrel bornavirus 1, Germany, 2005 to 2018
por: Tappe, Dennis, et al.
Publicado: (2019)

Symptom-Based Ebola Risk Score for Ebola Virus Disease, Conakry, Guinea
por: Ingelbeen, Brecht, et al.
Publicado: (2018)

Ebola Virus Transmission Initiated by Systemic Ebola Virus Disease Relapse
por: Mbala-Kingebeni, Placide, et al.
Publicado: (2021)

Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes
por: Wawina-Bokalanga, Tony, et al.
Publicado: (2021)

N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile
por: Garcia-Rubia, Alfonso, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ghg5putiq6kp76j7ut12o3lg2